Please assess the completion status of the following clinical trial:

Trial Title: Use of Ibandronate in Diabetic Patients

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age of at least 55 years at the time of screening~* postmenopausal woman~* diagnosis of osteoporosis~Exclusion Criteria:~* history of osteoporosis treatment~* underlying disease (e.g., heart failure, liver disease, renal disease, or malignancy)~* the use of drugs that affect bone metabolism (e.g., steroids, immunosuppressants, gonadotropin-releasing hormone agonists, aromatase inhibitors, thiazolidinedione drugs, anticonvulsants, and antidepressants)~* history of adverse effects of bisphosphonate or difficulty taking the drug due to an inability to sit or the presence of upper gastrointestinal disease

- Gender: FEMALE
- Minimum Age: 55 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Non-diabetes (Type: ACTIVE_COMPARATOR): postmenopausal women with normal glucose tolerance
- diabetes (Type: EXPERIMENTAL): postmenopausal women with type 2 diabetes

Based on this trial design, predict the completion outcome and termination type (if applicable).